Y. Yosaatmadja

Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase

J.A. Newman, A. Douangamath, Setayesh Yadzani et al. · Nature Communications · 2021 · 232 citations · Full text

Binding mode of the breakthrough inhibitor AZD9291 to epidermal growth factor receptor revealed

Y. Yosaatmadja, Shevan Silva, James M. Dickson et al. · Journal of Structural Biology · 2015 · 145 citations

Signal Transduction, Signaling Pathway, G Protein-coupled Receptor +9

TAS‐120 Cancer Target Binding: Defining Reactivity and Revealing the First Fibroblast Growth Factor Receptor 1 (FGFR1) Irreversible Structure

Maria Kalyukina, Y. Yosaatmadja, Martin Middleditch et al. · ChemMedChem · 2019 · 118 citations

Crystal Structures of Three Classes of Non-Steroidal Anti-Inflammatory Drugs in Complex with Aldo-Keto Reductase 1C3

Jack U. Flanagan, Y. Yosaatmadja, Rebecca Teague et al. · PLoS ONE · 2012 · 66 citations · Full text

Crystal Structure, Aldo-keto Reductase, Chemoprevention Strategy +17

Characterization of the SARS-CoV-2 ExoN (nsp14ExoN–nsp10) complex: implications for its role in viral genome stability and inhibitor identification

Hannah T. Baddock, Sanja Brolih, Y. Yosaatmadja et al. · Nucleic Acids Research · 2021 · 62 citations · Full text

Viral Genome Stability, Virus Structure, Viral Replication +12